1. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Issue 10264 (28th November 2020) Authors: Mackenzie, Isla S; Ford, Ian; Nuki, George; Hallas, Jesper; Hawkey, Christopher J; Webster, John; Ralston, Stuart H; Walters, Matthew; Robertson, Michele; De Caterina, Raffaele; Findlay, Evelyn; Perez-Ruiz, Fernando; McMurray, John J V; MacDonald, Thomas M; Aziz, J.; Dobson, G.; Doney, A.S.F.; Fl... Journal: Lancet Issue: Volume 396:Issue 10264(2020) Page Start: 1745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reliable exclusion of prognostically significant coronary disease in left ventricular dysfunction by cardiac MRI. Issue 2 (February 2017) Authors: Thompson, A.C.M.; Crilley, J.G.; Wilson, D.W.; Hungin, A.P.S.; Fuat, A.; Murphy, J.J.M. Journal: Clinical radiology Issue: Volume 72:Issue 2(2017) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗